2019-11-15T11:51:58-06:00 2018-12-31 521853933 JONES MARESCA & MCQUADE PA 10500 LITTLE PATUXENT PARKWAY SUITE 770 COLUMBIA MD 21044 990 2018-01-01 522320756 ACCELERATE BRAIN CANCER CURE INC ACCE 2024193140 1717 RHODE ISLAND AVENUE NW NO 700 WASHINGTON DC 20036 MAX WALLACE PRESIDENT AND CEO 2024193140 2019-11-15 1 LISA CHEIFETZ P01444196 4108840220 64.88.174.3 2019-11-15 11:04:02 ES P A02FDE1BB5C34FAEC78D97DBCBA9E94617D1657A 8135A10533E138772E75B7028466B6AE3A842BF5 2018 2020-03-31 21:24:44Z MAX WALLACE 1717 RHODE ISLAND AVENUE NW NO 700 WASHINGTON DC 20036 2299618 0 X WWW.ABC2.ORG X 2001 DC ACCELERATE BRAIN CANCER CURE HAS A SINGLE FOCUS-TO HASTEN THE DISCOVERY OF A CURE FOR BRAIN CANCER. 8 8 9 300 0 0 1772747 1912674 0 0 9924 2681 0 0 1782671 1915355 715237 363475 0 0 967720 850117 0 0 574271 452089 370692 2135046 1584284 -352375 331071 2896513 3099618 408196 280230 2488317 2819388 TO ACCELERATE PROGRESS IN WHAT HAS BEEN AN UNDERSERVED FIELD OF RESEARCH; THE ORGANIZATION AIMS TO RAISE AWARENESS ABOUT BRAIN CANCER AND HELP MOBILIZE CRITICAL SCIENTIFIC RESEARCH THROUGH RESEARCH GRANTS. 0 0 669406 363475 ACCELERATE BRAIN CANCER CURE, INC. (ABC2) BELIEVES A FOCUSED AND AGGRESSIVE ENTREPRENEURIAL MODEL WILL INCREASE THE NUMBER OF THERAPIES DISCOVERED AND ENABLE THOSE THERAPIES TO BE AVAILABLE TO DOCTORS AND PATIENTS MORE QUICKLY. ABC2 PROVIDES RESEARCHERS WITH THE PIVOTAL SUPPORT THEY NEED TO MAKE CRITICAL BREAKTHROUGHS. IT FUNDS TRANSLATIONAL RESEARCH AIMED AT FINDING THE FASTEST POSSIBLE ROUTE TO A CURE. ABC2 SUPPORTS A RANGE OF MEDICAL RESEARCH ORGANIZATIONS. 669406 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 16 0 1 9 1 0 0 0 0 0 0 0 0 0 0 0 0 X 8 8 1 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 0 0 0 CA NY X THE ORGANIZATION 2024193140 1717 RHODE ISLAND AVENUE NW NO 700 WASHINGTON DC 20036 STEVE CASE CHAIRMAN & CO-FOUNDER 1.00 X X 0 0 0 STACEY CASE CO-FOUNDER 1.00 X 0 0 0 NANCY PFUND MEMBER 1.00 X 0 0 0 DAVID COLE MEMBER 1.00 X 0 0 0 JEAN CASE CO-FOUNDER 1.00 X 0 0 0 DOUG HOLLADAY MEMBER 1.00 X 0 0 0 JONATHAN WEINBERG MEMBER 1.00 X 0 0 0 GARY WIMMER MEMBER 1.00 X 0 0 0 MAX WALLACE PRESIDENT AND CEO 40.00 X 305599 0 15688 DAVID SANDAK VP, SECRETARY/TREASURER 40.00 X 163926 0 16856 469525 0 32544 2 0 1 0 0 1107743 804931 5196 1912674 5406 5406 15798 14743 3780 1055 -3780 -2725 -2725 365740 1107743 365740 0 1915355 0 0 2681 X 363475 363475 502069 96516 147610 257943 274788 52225 80754 141809 6597 997 1632 3968 21602 5239 6663 9700 45061 7438 12944 24679 669 669 53300 53300 158982 47325 1446 110211 21360 7664 10933 2763 18513 3600 11313 3600 55970 53771 1822 377 15807 15235 534 38 3188 3188 21309 15621 5688 LICENSE AND REGISTRATIO 12368 300 1987 10081 WEBSITE & AV 9226 124 9102 1584284 669406 340607 574271 38013 2551650 2878185 303684 163206 513 33147 6909 39128 28016 8001 11112 31 1680 2896513 3099618 86320 129415 250000 100000 71876 50815 408196 280230 X 2184101 2618169 304216 201219 2488317 2819388 2896513 3099618 331071 0 X X 0 1 X 1 0 X 2154714 2575366 1961022 1772747 1912674 10376523 2154714 2575366 1961022 1772747 1912674 10376523 666923 9709600 649 2017 1732 6629 5406 16433 10392956 0.93420 0.90350 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 30249 19137 11112 8879 8879 0 11112 DUE TO AFFILIATED ENTRY 50815 50815 X 2369407 88312 365740 454052 1915355 0 1915355 2038336 88312 365740 454052 1584284 0 1584284 PART X, LINE 2: ABC2 BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS OR THAT WOULD HAVE AN EFFECT ON ITS TAX-EXEMPT STATUS. THERE ARE NO UNRECOGNIZED TAX BENEFITS OR LIABILITIES THAT NEED TO BE RECORDED. PART XI, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSES 365,740. PART XII, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSES 365,740. RACE FOR HOPE 1050302 931113 119189 119189 OVER THE EDGE - DC 162803 75381 87422 87422 3 260378 101249 159129 159129 1473483 1107743 365740 365740 365740 0 1 SYAPSE INC 101 UNIVERSITY AVENUE SUITE 230 PALO ALTO CA 94301 263457459 25000 TO USE SYAPSE'S SOFTWARE TO INTERPRET RAW GENOMIC DATA FOR BRAIN CANCER CLINICAL RESEARCH PURPOSES. JOHNS HOPKINS UNIVERSITY - MONTGOMERY 9601 MEDICAL CENTER DR ROCKVILLE MD 20850 520595110 501(C)(3) 72992 PATENTS UNC-CHAPEL HILL 20 DUKE MEDICINE CIR DURHAM NC 27710 566001393 501(C)(3) 25000 SUPPORT THE PROJECT TITLED "3D BRAIN TISSUE DRUG AND DIAGNOSTICS ASSAY FOR TARGETING GLIOBLASTOMA TUMOR HETEROGENEITY EARLY SIGNAL FOUNDATION INC 311 WEST 43RD STREET NEW YORK NY 10036 813198566 501(C)(3) 9363 REIMBURSEMENT FOR SENSORS AND SUPPLIES FOR ACCELERATE BRAIN CANCER CURE GRANT ACTIVITIES COLUMBIA UNIVERSITY PO BOX 29789 GENERAL POST OFFICE NEW YORK NY 10087 135598093 501(C)(3) 99000 FOR THE GRANT TITLED" GLIOBLASTOMA LIVING BIOBANK PROJECT" BROAD INSTITUTE INC 415 MAIN STREET CAMBRIDGE MA 02142 263428781 501(C)(3) 101142 GBM CASES FOR CLIA SOMTIC WES - 2017 5 1 PART I, LINE 2: ABC2 CLOSELY MONITORS THE PROGRESS OF THE RESEARCHERS IT FUNDS THROUGH ITS GRANT PROGRAM. THE ORGANIZATION REQUIRES SCIENTIFIC PROGRESS REPORTS AND COMPLETE FINANCIAL ACCOUNTING OF EXPENDITURES BEFORE RELEASING ADDITIONAL FUNDS AS WELL AS FINAL GRANT REPORTS INCLUDING FINANCIAL REPORTS. IN ADDITION, ABC2 HOLDS AN ANNUAL SCIENTIFIC MEETING AT WHICH TIME CERTAIN GRANTEES PRESENT THEIR PROGRESS. X X 0 0 0 0 0 0 0 0 0 MAX WALLACE PRESIDENT AND CEO 305599 0 0 0 0 0 0 0 15688 0 321287 0 0 0 DAVID SANDAK VP, SECRETARY/TREASURER 163926 0 0 0 0 0 6701 0 10155 0 180782 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 STEPHEN CASE, CHAIRMAN & BOARD MEMBER AND JEAN CASE, BOARD MEMBER ARE CO-FOUNDERS AND SPOUSES. STACEY CASE, BOARD MEMBER AND CO-FOUNDER, IS THE SISTER-IN-LAW OF STEPHEN CASE. THESE BOARD MEMBERS ALSO HAVE BUSINESS RELATIONSHIPS. FORM 990, PART VI, SECTION B, LINE 11B MAX WALLACE, THE CHIEF EXECUTIVE OFFICER OF ACCELERATE BRAIN CANCER CURE, INC. REVIEWS AND SIGNS THE 990. THE 990 IS ALSO REVIEWED BY THE FINANCE COMMITTEE BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD OF DIRECTORS REVIEWS THE CONFLICT OF INTEREST POLICY AT ITS ANNUAL BOARD MEETING. INDEPENDENCE IS ALSO CONFIRMED PRIOR TO THE AWARDING OF ANY EXPENDITURE RESPONSIBILITY GRANT. FORM 990, PART VI, SECTION B, LINE 15 THE CHIEF EXECUTIVE OFFICER JOINED THE ORGANIZATION IN 2008. AS PART OF THE EXECUTIVE SEARCH PROCESS AN INDEPENDENT SEARCH FIRM PERFORMED AN INDUSTRY COMPENSATION ANALYSIS. THE LAST COMPENSATION REVIEW TOOK PLACE ON DECEMBER 2015. THE ORGANIZATION HAD NO KEY EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANICAL STATEMENTS AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTING & PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 47,325. MANAGEMENT AND GENERAL EXPENSES 1,446. FUNDRAISING EXPENSES 110,211. TOTAL EXPENSES 158,982. FORM 990, PART XII, LINE 2C THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.